Anti-GPRC5D CAR-TCell Therapy: A Breakthrough for Multiple Myeloma
In May 2023, a multicenter study led by Professor KaiLin Xu's team from Blood Diseases Institute, Xuzhou Medical University was published in the top international academic journal——Journal of Clinical Oncology(IF=50.717), titled "Anti-G Protein-Coupled Receptor,…